| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_947b16da52f37f7a3042433baa423794 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y305-02006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate |
2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edb853609bcb2d49b195bad207527196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8497ae956a09d346edded8c690a4ee7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8bbf87ff4ad4b140df10acf3fa2c6ab |
| publicationDate |
2021-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2806426-T3 |
| titleOfInvention |
Beta-lactamase formulations and uses thereof |
| abstract |
A modified release formulation comprising a beta-lactamase, wherein the formulation comprises at least one modified release granule and wherein each modified release granule comprises: 10-20% by weight of beta-lactamase comprising an amino acid sequence that has at least 95% sequence identity with SEQ ID NO: 1, 3 or 6; 20-30% by weight of sucrose sphere; 30-40% by weight of hydroxypropyl cellulose; 15-25% by weight of an enteric polymer; 1.5-2.5% by weight of triethyl citrate; 0.5-1.5% by weight of glyceryl monostearate; 0.1-1.0% by weight of polysorbate-80; and 1-2% by weight of buffer salt. |
| priorityDate |
2014-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |